PORTALUPPI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 26.695
AS - Asia 13.355
EU - Europa 7.596
SA - Sud America 2.126
AF - Africa 279
Continente sconosciuto - Info sul continente non disponibili 236
OC - Oceania 39
Totale 50.326
Nazione #
US - Stati Uniti d'America 26.204
SG - Singapore 4.953
CN - Cina 3.272
UA - Ucraina 1.704
BR - Brasile 1.617
IT - Italia 1.584
HK - Hong Kong 1.312
DE - Germania 1.278
VN - Vietnam 1.265
TR - Turchia 1.058
GB - Regno Unito 758
FI - Finlandia 546
FR - Francia 436
SE - Svezia 418
RU - Federazione Russa 401
BD - Bangladesh 356
JP - Giappone 274
IN - India 255
MX - Messico 214
CA - Canada 186
AR - Argentina 175
ID - Indonesia 90
NL - Olanda 83
ZA - Sudafrica 82
EC - Ecuador 77
IQ - Iraq 75
PL - Polonia 75
CO - Colombia 69
PK - Pakistan 68
ES - Italia 65
VE - Venezuela 57
PH - Filippine 55
MA - Marocco 51
MY - Malesia 45
SA - Arabia Saudita 40
AT - Austria 37
PE - Perù 37
CL - Cile 36
AU - Australia 35
BE - Belgio 32
UZ - Uzbekistan 31
PY - Paraguay 30
TN - Tunisia 29
LT - Lituania 26
AE - Emirati Arabi Uniti 24
CZ - Repubblica Ceca 22
KE - Kenya 22
EG - Egitto 19
KR - Corea 18
NG - Nigeria 18
LB - Libano 17
CR - Costa Rica 16
RO - Romania 16
CH - Svizzera 15
NP - Nepal 15
TH - Thailandia 15
IE - Irlanda 14
IL - Israele 14
JM - Giamaica 14
JO - Giordania 14
BH - Bahrain 12
OM - Oman 12
UY - Uruguay 12
BG - Bulgaria 11
BO - Bolivia 11
GT - Guatemala 11
TT - Trinidad e Tobago 11
PS - Palestinian Territory 10
PT - Portogallo 9
ET - Etiopia 8
NO - Norvegia 8
AZ - Azerbaigian 7
BY - Bielorussia 7
DZ - Algeria 7
GE - Georgia 7
HU - Ungheria 7
KZ - Kazakistan 7
PA - Panama 7
RS - Serbia 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
EU - Europa 6
GA - Gabon 6
HR - Croazia 6
SN - Senegal 6
AO - Angola 5
HN - Honduras 5
IR - Iran 5
LV - Lettonia 5
PR - Porto Rico 5
AL - Albania 4
GR - Grecia 4
KW - Kuwait 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
QA - Qatar 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
Totale 50.034
Città #
Singapore 3.201
Fairfield 2.740
Woodbridge 2.497
Ashburn 2.395
Jacksonville 1.844
Houston 1.798
Chandler 1.349
Hong Kong 1.293
San Jose 1.204
Ann Arbor 1.186
Santa Clara 1.149
Seattle 1.069
Wilmington 966
Cambridge 846
Beijing 741
Izmir 539
Nanjing 474
Ho Chi Minh City 422
Princeton 335
Los Angeles 315
Hanoi 299
Dallas 287
New York 279
Lauterbourg 278
Tokyo 257
San Diego 253
Boardman 238
Council Bluffs 216
Milan 189
Munich 187
Carrara 176
Helsinki 169
Shenyang 158
Mexico City 144
São Paulo 133
Hefei 131
Nanchang 119
Tianjin 115
Changsha 113
Falls Church 104
Ferrara 100
Hebei 94
San Mateo 93
Orem 89
London 87
Shanghai 87
Buffalo 83
Jinan 78
Jiaxing 76
Washington 76
Toronto 72
Addison 68
Norwalk 67
Chicago 65
Da Nang 62
Rome 62
Warsaw 60
Haiphong 59
Redwood City 55
San Francisco 55
Brooklyn 54
Chennai 50
Denver 50
Moscow 50
Mountain View 46
Montreal 44
Zhengzhou 44
Johannesburg 43
Atlanta 42
Rio de Janeiro 42
Philadelphia 41
Kunming 40
The Dalles 39
Turku 39
Belo Horizonte 38
Dearborn 37
Stockholm 35
Baghdad 34
Frankfurt am Main 34
Saint Petersburg 34
Boston 32
Verona 32
Quito 31
Amsterdam 30
Ningbo 30
Orange 30
Guangzhou 29
Phoenix 28
Hangzhou 27
Jakarta 26
Poplar 26
Brussels 25
Mumbai 25
Tappahannock 25
Auburn Hills 24
Curitiba 24
Hải Dương 24
Tashkent 24
Columbus 23
Goiânia 23
Totale 33.070
Nome #
Chronotherapy of blood pressure medications to improve management of hypertension and reduce vascular risk 378
Caffeine alters A(2A) adenosine receptors and their function in human platelets 326
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 306
Cronofarmacologia e cronoterapia dell'ipertensione arteriosa 299
Circadian pattern in occurrence of renal colic in an emergency department: analysis of patients' notes 275
Low molecular weight heparins and glomerular filtration rate: A report to be considered 261
Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension 259
Circadian profile of plasma calcitonin gene-related peptide in healthy man 247
Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program 242
Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults 240
An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin 232
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 231
Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea 230
Estimation of renal function in patients with eating disorders 224
Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes 223
Diurnal and twenty-four hour patterning of human diseases: Acute and chronic common and uncommon medical conditions 223
Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy 221
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 220
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 219
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 219
The Fast Fourier Transform in the Analysis of the Normal Phonocardiogram 218
Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension 217
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 214
Regarding "The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions" 214
Cocaine and acute vascular diseases 214
Cardiomechanical effect of k-strophanthoside administered to healthy volunteers by the rectal route 212
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial 210
Circadian and circannual rhythmicity in the occurrence of subarachnoid hemorrhage 209
Morning preference in onset of symptomatic third-degree atrio-ventricular heart block 209
Chronotherapy of hypertension 205
Out-of-hospital sudden death referring to an emergency department 204
Mechanism of influence of PR interval on loudness of first heart sound 204
ST segment monitoring as a predictor of reperfusion after blood transfusion in a patient with acute non-Q-wave myocardial infarction 201
Chronobiologic aspects of ischemic coronary artery disease 198
Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward 197
2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). 197
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 196
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease 196
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 195
Circadian rhythms in mouse blood coagulation 195
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 194
Bioavailability of digoxin improved by pharmaceutical manufactoring process 194
Circadian rhythms and cardiovascular health 194
Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention 193
Chronobiological aspects of pulmonary thromboembolism 192
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 191
Diagnosis of mitral valve diseases using indirect (esophageal) left atrial pulse 190
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure 190
Circadian variation in onset of acute cardiogenic pulmonary edema is independent of patients' features and underlying pathophysiological causes 189
Evidence-based statin prescription for cardiovascular protection in renal impairment 188
Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease 187
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 187
Antagonisti del recettore dell’Angiotensina II e scompenso cardiaco. Domande e risposte per il medico pratico 185
Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta 185
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design 184
Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure 184
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 182
The main heart sounds as vibrations of the cardiohemic system: old controversy and new facts 181
Estimation of glomerular filtration rate and assessment of risk of stroke in an emergency setting 181
Antihypertensive efficacy and safety of olmesartan medoximil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trials. 180
Biological Rhythms, Drug Delivery, and Chronotherapeutics 180
SEASONAL VARIATION IN THE RUPTURE OF ABDOMINAL AORTIC ANEURYSMS 178
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 177
Atrial strain is the main determinant of release of atrial natriuretic peptide 176
Phonometric study of the human first heart sound 176
Circadian variation in the occurrence of fatal pulmonary embolism. Differences depending on sex and age 176
Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina 175
Risk factors for metabolic syndrome in stable Italian renal transplant patients 175
Pulmonary hypertension in dialysis patients: a cross-sectional Italian study 175
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 174
Disturbi d'ansia in Medicina Interna 174
Circadian rhythms and medical diseases: Does it matter when drugs are taken? 174
Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation 174
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) 173
Circadian and cyclic environmental determinants of blood pressure patterning and implications for therapeutic interventions 173
Antiossidanti, pro-ossidanti e valutazione della capacità antiossidante 173
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 172
Circadian variation in onset of epistaxis: analysis of hospital admissions 172
Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension 171
Ethics and methods for biological rhythm research on animals and human beings 171
Seasonal variation in the occurrence of nontraumatic rupture of thoracic aorta 171
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 169
Risk factors for renal disease and urinary abnormalities in men and women: Data from the world kidney day in the province of Ferrara, Italy 169
May allergic syndrome represent valid trigger for Tako-tsubo cardiomyopathy? A systematic review of reported cases. 169
Chronobiologic vs. sphygmomanometric assessment of hypertension in a hospital setting 168
A2A adenosine receptors and chronic caffeine intake in human neutrophils 168
Chronobiological patterns of onset of acute cerebrovascular diseases 168
Loss of nocturnal blood pressure fall in patients with renal impairment 167
Esophageal left atrial pulse in mitral valve prolapse 166
Delta opioid receptor involvement in endocrine pathophysiology 166
Circadian variation in the onset of acute critical limb ischemia 166
Typical chest pain and onset of acute myocardial infarction in a prospective cohort of emergency calls 166
Twenty-four-hour pattern of angina pectoris, acute myocardial infarction and sudden cardiac death: role of blood pressure, heart rate and rate-pressure product circadian rhythms 166
Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia 165
Ambulatory blood pressure monitoring: Application to clinical medicine and antihypertension medication trials 165
Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure 165
Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls 164
Night shift and impaired endothelial function: Circadian out-of-synch may play a role 164
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 164
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 163
Totale 19.749
Categoria #
all - tutte 217.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.929
Totale 227.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.476 118 427 342 140 143 129 193 206 120 270 395 993
2022/20233.148 362 100 121 395 489 522 83 309 419 20 201 127
2023/20241.232 181 227 76 50 88 92 45 86 16 23 48 300
2024/20255.546 232 149 433 138 728 555 210 421 805 634 728 513
2025/202615.987 1.323 705 1.542 2.166 2.165 1.112 1.682 842 1.517 1.826 625 482
2026/2027720 720 0 0 0 0 0 0 0 0 0 0 0
Totale 50.326